NCT06315179 Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
| NCT ID | NCT06315179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-05-10 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-05-10 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.
Eligibility Criteria
Inclusion Criteria: * Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC) Exclusion Criteria: * Evidence of Other Complicating Medical Issues: * Other serious medical conditions, such as neurological, liver, kidney, or systemic disease * Pregnancy * Tobacco, alcohol, or illicit drug abuse
Contact & Investigator
Betty (Hengqi) Zheng, MD
PRINCIPAL INVESTIGATOR
Seattle Children's Hospital, University of Washington
Frequently Asked Questions
Who can join the NCT06315179 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 21 Years, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06315179 currently recruiting?
Yes, NCT06315179 is actively recruiting participants. Contact the research team at mason.nuding@seattlechildrens.org for enrollment information.
Where is the NCT06315179 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06315179 clinical trial?
NCT06315179 is sponsored by Seattle Children's Hospital. The principal investigator is Betty (Hengqi) Zheng, MD at Seattle Children's Hospital, University of Washington. The trial plans to enroll 200 participants.